Insider · CIK 0001820187
Marlan D Walker
Files at TXMD (TherapeuticsMD, Inc.). First filing Apr 10, 2025, latest Apr 15, 2025.
In brief
Marlan D Walker files SEC Form 4 as CEO at TXMD (TherapeuticsMD, Inc.). Since Apr 10, 2025, Marlan D Walker has reported 2 open-market buys worth $2,483 and 0 open-market sells worth $0, the latest filed on Apr 15, 2025.
A track record needs three past buys with six months of prices behind them; Marlan D Walker has 0, so none is measured yet.
The newest scored trade: bought $489 of TXMD on Apr 14, 2025, filed Apr 15, 2025, scored 33 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXMD: TherapeuticsMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | TherapeuticsMD, Inc. | $489 490 shares | +1% | - | |
| 33Weak | TherapeuticsMD, Inc. | $1,994 2,303 shares | +3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 6, 2023 | TXMD TherapeuticsMD, Inc. | 28,134 0.27% of outstanding | $70k | Dec 6, 2023 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | TXMD TherapeuticsMD, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +67,492 | $0.00 | $0 | 67,492 | Nov 5, 2025 |
| Apr 14, 2025 | TXMD TherapeuticsMD, Inc. | POpen-market purchase Common Stock | +490 | $1.00 | $489 | 73,639 | Apr 15, 2025 |
| Apr 9, 2025 | TXMD TherapeuticsMD, Inc. | POpen-market purchase Common Stock | +1,136 | $0.87 | $994 | 71,982 | Apr 10, 2025 |
| Apr 10, 2025 | TXMD TherapeuticsMD, Inc. | POpen-market purchase Common Stock | +1,167 | $0.86 | $1,000 | 73,149 | Apr 10, 2025 |
Questions about Marlan D Walker
Answered from the filings on this page, as of the latest one.
Is Marlan D Walker buying or selling?
Not in the last 12 months. Marlan D Walker's latest open-market trade on SEC Form 4 was bought $489 of TXMD on Apr 14, 2025.
How did Marlan D Walker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marlan D Walker has 0.
Where does Marlan D Walker file Form 4?
Marlan D Walker has filed Form 4 at TXMD (TherapeuticsMD, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.